No. Sino Biopharmaceutical (1177.HK) does not pass the AAOIFI Shari’ah Standard 21 screen.
Not settled. Sino Biopharmaceutical (1177.HK) could not be confirmed either way under the Catholic screen based on the USCCB investment guidelines.
Yes. Sino Biopharmaceutical (1177.HK) passes the Biblically Responsible Investing (BRI) screen.